Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.5.1.61: hydroxymethylbilane synthase

This is an abbreviated version!
For detailed information about hydroxymethylbilane synthase, go to the full flat file.

Word Map on EC 2.5.1.61

Reaction

4 porphobilinogen +

H2O
=
Hydroxymethylbilane
+ 4 NH3

Synonyms

(HMB)-synthase, AN0121.3, EC 4.3.1.8, HemC, hepatic porphobilinogen deaminase, HMB synthase, HMB-S, HMBS, HMBS1a-synthase, HMBS1b-synthase, HMBS2a-synthase, HMBS2b-synthase, human non-erythropoietic PBGD isoform, human PBGD, human porphobilinogen deaminase, hydroxymethylbilane synthase, More, PBG deaminase, PBG-D, PBG-deaminase, PBGD, PGB-D, porphobilinogen ammonia-lyase (polymerizing), porphobilinogen deaminase, pre-uroporphyrinogen synthase, preuroporphyrinogen synthase, preuroporphyrinogen synthetase, synthase, uroporphyrinogen I, uPBGD, UPGI-S, URO-S, urogenI synthase, uroporphyrinogen I synthase, uroporphyrinogen I synthetase, uroporphyrinogen synthase, uroporphyrinogen synthetase

ECTree

     2 Transferases
         2.5 Transferring alkyl or aryl groups, other than methyl groups
             2.5.1 Transferring alkyl or aryl groups, other than methyl groups (only sub-subclass identified to date)
                2.5.1.61 hydroxymethylbilane synthase

Engineering

Engineering on EC 2.5.1.61 - hydroxymethylbilane synthase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
K55Q
-
K55Q mutant
K55Q/K59Q
-
K55Q-K59Q mutant, lower specific activity than the wild-type enzyme
K59Q
-
K59Q mutant, lower specific activity than the wild-type enzyme
A84T
type OregonAR (c250G>A), autosomal recessive, therefore phenotype is homozygous, about 35% wild type activity
L64S
c.189dupT mutant type Saskatchewan with duplication that leads to a frameshift and thus to a trunkated enzyme due to a premature stop codon 65 and the exchange L64S, autosomal dominant
R149W
type Missouris (c.445C>T), substitution identical to human mutation but there leading to an nonsense mutation, autosomal dominant, less than 1% wild type activity
887insA
-
site-directed mutagenesis, the mutant shows reduced expression and subcellular distribution compared to the wild-type enzyme
A226P
A31P
0.6% of wild-type activity
A31T
0.50% of wild-type activity
D99H
3.3% of wild-type activity
E250D
G218R
0.1% of wild-type activity
G24S
c.70G>A (p.Gly24Ser)
G748A
-
site-directed mutagenesis, the mutant shows reduced expression and subcellular distribution compared to the wild-type enzyme
G748C
-
site-directed mutagenesis, the mutant shows reduced expression and subcellular distribution compared to the wild-type enzyme
H300L
c.899_900delinsTGCCTGCATCTG (p.His300LeuFsX10)
K132N
site-directed mutagenesis, the mutant shows no conformational or kinetic defect, no loss in relative activity (97% of wild-type activity) at standard conditions nor change in Vmax and Km. The mutation is not associated to acute intermittent porphyria, AIP
K98R
0.70% of wild-type activity
L170R
0.6% of wild-type activity
L170V
72.6% of wild-type activity
N169I
6.2% of wild-type activity
N322K
c.965_966insA (p.Asn322LysfsX36)
Q204K
c.610C>A, exon 10, missense mutation, 46% wild type activity, 50 mM Tris-HCl, pH 8.2, 0.1% bovine serum albumin, 0.1% Triton, pH 8.2, 37°C, 1 h in the dark
Q34K
0.2% of wild-type activity
Q34R
0.7% of wild-type activity
Q356E
95.7% of wild-type activity
R116W
site-directed mutagenesis, the mutant shows 0.5% of wild-type activity and defects in conformational stability. The mutation is associated to acute intermittent porphyria, AIP
R149L
0.1% of wild-type activity
R149Q
R149X
identification of a nonsense mutation in the PBGD gene on chromosome 11q23.3, which harbors the mutations causing acute intermittent porphyria, as the underlying genetic defect in Chester porphyria, phenotype, overview
R150I
0.02% of wild-type activity
R150Q
0.8% of wild-type activity
R167Q
R167W
R173Q
R173Q/Q204K
R173Q is more severe with a resulting enzyme activity of nearly zero, the Q204K increases the negative effect, particularly on the protein stability, 50 mM Tris-HCl, pH 8.2, 0.1% bovine serum albumin, 0.1% Triton, pH 8.2, 37°C, 1 h in the dark
R173W
R195C
3% of wild-type activity
R325A
c.972_973insG (p.Arg325AlafsX33)
R32P
c.95G>C (p.Arg32Pro)
R73Q/Q204K
a complex monoallelic mutation c.[518G>A; c.610C>A] (p.[Arg173Gln;p.Gln204Lys])
S146C
69.9% of wild-type activity
S146G
81% of wild-type activity
S146I
2.3% of wild-type activity
S147P
0.2% of wild-type activity
S165C
69.9% of wild-type activity
S262C
46.3% of wild-type activity
S28C
1.2% of wild-type activity
S28N
0.8 % of wild-type activity
S96F
1.0 % of wild-type activity
T145I
0.4% of wild-type activity
T145N
0.8% of wild-type activity
T58I
0.70% of wild-type activity
V215E
site-directed mutagenesis, the mutant shows 30% of wild-type activity and lower conformational stability and probably a perturbed elongation process, also 70% loss in both activity and Vmax. The mutation is associated to acute intermittent porphyria, AIP
V215M
-
19.4% residual activity compared to the wild type enzyme
L116K
the specific activity of this recombinant mutant enzyme is 5fold higher than that of the recombinant wild type enzyme, catalyzes the formation of uroporphyrinogen I in addition to uroporphyrinogen III
D44A
specific activity is only about 2% of that of the wild type enzyme
E63A
reduced activity
H78L
reduced activity
Q200L
mutant lacks the dipyrromethane cofactor and completely loses the catalytic activity
additional information